Open Access

Predominance of atypical genotypes of Toxoplasma gondii in free-roaming chickens in St. Kitts, West Indies

  • Clare M. Hamilton1, 2Email author,
  • Patrick J. Kelly2,
  • Kenneth Boey2, 3,
  • Tatiana M. Corey2,
  • Hieuhanh Huynh2,
  • Deidra Metzler2,
  • Isabelle Villena4, 5,
  • Chunlei Su6,
  • Elisabeth A. Innes1 and
  • Frank Katzer1
Parasites & Vectors201710:104

https://doi.org/10.1186/s13071-017-2019-6

Received: 22 September 2016

Accepted: 7 February 2017

Published: 27 February 2017

Abstract

Background

Toxoplasma gondii is a worldwide protozoan parasite of felids which can infect almost all warm-blooded animals, including humans. Free-roaming chickens are good indicators of environmental contamination with T. gondii oocysts because they feed from the ground. Previous research has demonstrated a high seroprevalence of T. gondii in domestic animals on St. Kitts but little is known about the genotypes circulating in the environment.

Methods

Hearts and brains from 81 free-roaming chickens in St. Kitts were digested and inoculated into 243 Swiss Webster mice in a bioassay. DNA was extracted from digested chicken tissues and the brains of all mice, and screened for T. gondii. Positive samples were genotyped using restriction fragment length polymorphism. Chicken sera were also screened for T. gondii antibodies using a modified agglutination test (MAT).

Results

Overall, 41% (33 out of 81) of chickens were positive for T. gondii either by serology and/or by PCR. Antibodies to T. gondii were detected by MAT in 32% (26 out of 81) of chickens, and T. gondii DNA was detected in mouse brains representing 26% (21 out of 81) of chickens. Genotyping of 21 DNA isolates, using polymorphisms at 10 loci, including SAG1, SAG2 (5′-3′ SAG2 and alt.SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico, revealed that 7 were ToxoDB genotype #141, 6 were #1 (Type II), 3 were #13, 3 were #265, one was #264 and one was #2 (Type III). Genotypes #13 and #141 appear to be more virulent.

Conclusions

The results of this study highlight the greater genetic diversity of T. gondii circulating in the Caribbean region, with potentially different degrees of virulence to humans.

Keywords

Toxoplasma gondii Chickens Genotyping St. Kitts West Indies

Background

Toxoplasma gondii is a parasite of felids which can infect almost all warm-blooded animals, including humans [1]. Worldwide seroprevalences vary but it has been suggested that around one third of people have been infected with this parasite [2]. Transmission routes include ingestion of tissue cysts in infected meat, ingestion of sporulated oocysts (shed by felids) in contaminated food, water, or directly from the environment, and via vertical transmission, if a woman experiences a primary infection during pregnancy. Symptoms of toxoplasmosis are usually mild; however, immune-compromised people and congenitally infected infants can suffer severe, and even fatal, clinical signs [3].

Different factors may affect the severity of toxoplasmosis, including the infecting stage of the parasite, the size of inoculating dose, and the virulence of the infecting strain [4]. Historically, T. gondii was thought to have a clonal population structure comprising three dominant lineages (Types I, II and III) based on restriction fragment length polymorphism [5, 6]. However, there are indications of greater genetic variability with severe cases of toxoplasmosis in patients from South America being linked to genetically distinct strains of T. gondii, highlighting a greater genetic variability than previously thought [7, 8].

In 2002, Dubey et al. [9] initiated a worldwide survey of T. gondii in free-roaming chickens with the goal of characterising the genetic diversity of T. gondii on a global basis [10]. Free-roaming chickens are considered one of the most important hosts for studying the epidemiology of T. gondii because they feed from the ground and are therefore good indicators of environmental contamination with oocysts [10]. Also, the tissues of infected chickens are a good source of infection for cats, and potentially for humans if the meat is consumed undercooked. Strains of T. gondii have been characterized from free-roaming chickens in South America [9], Central America [11], the Caribbean [12], Asia [13], Africa [14] and Europe [15], and it is becoming apparent that isolates from South America, in particular Brazil, are genetically distinct [16].

Previous research in St. Kitts has demonstrated a high seroprevalence of T. gondii in domestic and feral cats [17, 18], as well as African green monkeys [19], livestock animals [20, 21] and dogs [22]. Genetic characterization of T. gondii isolated from livestock heart samples at the St. Kitts abattoir [21] and from feral cats [18] and dogs [22] revealed that the Type III genotype was predominant which was similar to other findings from Caribbean islands in this region [12], although atypical genotypes have also been reported [18, 21, 22].

In order to investigate the diversity of T. gondii genotypes circulating in the Caribbean, we isolated and genetically characterised viable isolates from free-roaming chickens in St. Kitts.

Methods

Animals

This study was carried out between September 2014 and December 2014, following ethical approval from the Institutional Animal Care and Use Committee at RUSVM (Project Submission 30/020). Free-roaming chickens (n = 81) were collected, with permission from St. Kitts and Nevis Department of Agriculture and Chief Veterinary Officer, from 9 different locations (9 chickens from each) around the island (Fig. 1). Chickens were euthanized humanely by lethal injection and blood, heart and brain were collected from each. Sera were isolated as previously described [21] and stored at -20 °C until required. Hearts and brains were transferred to re-sealable bags prior to processing as described below.
Fig. 1

Map of St. Kitts showing nine areas where chickens were collected and the genotypes identified in each area from this study and previous studies (italicised bold) in St. Kitts [20, 24] (map adapted from mapsof.net)

Serological examination

Aliquots of chicken sera were tested at the Toxoplasma Reference Laboratory (Reims, France) for reactive T. gondii antibodies using a modified agglutination test (MAT) [23]. Serum samples with an antibody titre of greater than or equal to 1:6 were considered positive.

Bioassay of chicken tissues for T. gondii

Hearts and brains from all 81 chickens were digested in acid-pepsin solution as previously described [21], with the following modifications: the brain and heart from each chicken were pooled, homogenised in 25 ml (approximately five volumes (w/v)) 0.9% saline solution and then mixed with 25 ml (approximately five volumes (w/v)) acid-pepsin solution (which had been pre-warmed to 37 °C). After processing, the resulting pellet was resuspended in 10 ml PBS prior to being neutralized with 7.5 ml 1.2% sodium carbonate and centrifuged at 1200× g for 10 min. Two ml sterile saline solution containing 400 IU/ml penicillin and 400 μg/ml streptomycin were used to resuspend the final pellet.

Three Swiss CD-1® IGS mice (Charles River Laboratory, Boston, MA, USA) per chicken were each inoculated with 400 μl of homogenate, and 400 μl was kept for DNA extraction (see below). Mice were monitored twice daily and euthanized either when they showed clinical signs of T. gondii infection, or when they reached the end of the experiment (day 28 post inoculation). Immediately after euthanasia, mice were bled by cardiac puncture, and sera were isolated following centrifugation of clotted whole blood at 2000× g for 5 min and stored at -20 °C. Sera were tested for T. gondii-specific antibodies using an indirect ELISA (ID Screen® Toxoplasmosis Indirect Multi-species, IDvet, Montpellier, France) according to manufacturer’s instructions. Brain and right lung from each mouse were transferred to clean 2 ml tubes and stored at -80 °C for DNA extraction and genotyping.

Detection of T. gondii DNA in digested chicken tissues

DNA was extracted from 400 μl of digested tissue homogenate per chicken using the Wizard® genomic DNA purification protocol (Promega Corporation, Southampton, UK) [24]. The final pellet of DNA was resuspended in 200 μl molecular-grade water and stored at -80 °C prior to use. Extraction controls were included within each group of DNA extractions as described previously [21]. PCR amplifications, targeting the ITS1 region between the 18S and 5.8S rRNA genes, were carried out in duplicate using conditions previously described [25]. In order to quantify the level of T. gondii DNA present in the digested chicken tissues (used as the mouse inocula), any samples positive by ITS1 PCR were also screened using a quantitative PCR, targeting the 529-bp repeat element, as previously described [21].

Genetic characterisation of T. gondii

The whole brain from each mouse was homogenised (in 1 ml PBS) by passing tissue through an 18G needle followed by a 21G needle. DNA was extracted from 400 μl brain homogenate using the method described above. All 243 samples were initially examined for the DNA of T. gondii using the nested ITS1 PCR described above. Samples which were positive were then genotyped utilising a multiplex nested PCR-RFLP targeting 10 genetic markers, including SAG1, SAG2 (5′-3′ SAG2 and alt.SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico. PCR-RFLP conditions for all markers were carried out as previously described [21]. Typing profiles were determined using RFLP banding profiles of reference strains [26].

In order to compare genotypes of T. gondii isolated from mouse tissues and chicken tissues, PCR-RFLP was carried out as described above using DNA extracted from the digested chicken tissues (mouse inoculum).

Statistical analysis

A two-way ANOVA was used to investigate the effects of genotype and quantity of T. gondii DNA in the inocula on the percentage of mouse mortality. A separate one-way ANOVA with LSD post-hoc tests was used to further investigate the effect of genotype on the percentage of mouse mortality. A P value of < 0.05 was deemed significant. The statistical software package Minitab 17 was used for all statistical analyses.

Results

Overall, 33 out of 81 (41%) chickens were positive for T. gondii either by serology (MAT-positive) and/or by ITS1 PCR, whereby T. gondii DNA was detected either in digested chicken tissues or in the brain tissues of inoculated mice (Table 1). Antibodies to T. gondii were detected by MAT in 32% (26 of 81) of chickens, with titres of 1:6 in 10, 1:10 in 5, 1:25 in 3, 1:50 in 4, 1:100 in 1, 1:400 in 1, 1:800 in 1, and 1:3200 in 1 chicken (Table 1). Toxoplasma gondii DNA was detected in the homogenised brain and heart tissues (used as the mouse inoculum) of 28% (23 of 81) of chickens (Table 1). Of these, 5 had an MAT titre of 1:6, 3 had a titre of 1:10, 2 had a titre of 1:25, 3 had a titre of 1:50, 1 had a titre of 1:400, 1 had a titre of 1:800, 1 had a titre of 1:3200, and 7 were seronegative with a titre of less than or equal to 1:3. Toxoplasma gondii DNA was detected in mouse brains representing 26% (21 of 81) chickens, including 4 chickens with an MAT titre of 1:6, 2 with a titre of 1:10, 2 with a titre of 1:25, 4 with a titre of 1:50, 1 with a titre of 1:400, 1 with a titre of 1:800, 1 with a titre of 1:3200, and also 6 seronegative chickens with titres of less than or equal to 1:3.
Table 1

Summary of Toxoplasma gondii isolation from free-roaming chickens in St. Kitts

Location

Parish

MAT

POSa

ITS1

POSb

Bioassay

POSc

MAT and/or PCR POSd

1

St. Georges Basseterre

2/9

2/9

2/9

3/9

2

St. Peters Basseterre

2/9

3/9

2/9

3/9

3

St. Thomas Middle Island

3/9

5/9

5/9

6/9

4

St. Thomas Middle Island

6/9

0/9

1/9

6/9

5

St. Anne Sandy Point

2/9

2/9

2/9

2/9

6

St. Paul Capisterre

4/9

3/9

3/9

4/9

7

St. John Capisterre

1/9

0/9

0/9

1/9

8

Christchurch

2/9

2/9

1/9

2/9

9

St. Mary Cayon

4/9

6/9

5/9

6/9

Total

 

26/81 (32%)

23/81 (28%)

21/81 (26%)

33/81 (41%)

aNumber of chickens seropositive/number of chickens tested

bNumber of chickens positive for T. gondii DNA (chicken tissues positive by ITS1 PCR)/number of chickens tested

cNumber of chickens positive by bioassay (where brain tissue from at least one mouse out of 3 was positive by ITS1 PCR)/number of chickens tested

dNumber of chickens T. gondii-positive by either serology (MAT) and/or PCR (either chicken tissues or mouse tissues)/Number of chickens tested

Thirty out of the 243 mice inoculated [representing 12 out of 81 chickens (15%)] had to be euthanized before the end of the experiment due to clinical signs of toxoplasmosis (Table 2).
Table 2

Burden of Toxoplasma gondii DNA in chicken tissues (used as mouse inocula)

Chicken IDa

qPCR

DNA (pg)

No. of mice infected (out of 3 inoculated)

No. of mice euthanized early due to infection (% mortality)b

1.6

Pos

0.3

3

0 (0)

1.8

Pos

1.5

3

0 (0)

2.1

Pos

11.1

3

3 (100)

2.3

Pos

1.8

3

3 (100)

2.7

Pos

0.04

0

0 (0)

3.2

Neg

0.0

3

0 (0)

3.4

Pos

0.3

3

0 (0)

3.5

Pos

0.7

3

3 (100)

3.6

Pos

0.1

3

1 (33.3)

3.8

Pos

5.6

3

2 (66.7)

5.1

Pos

6.3

3

3 (100)

5.2

Pos

13.6

3

2 (66.7)

6.1

Pos

21.6

3

3 (100)

6.2

Pos

1.1

3

3 (100)

6.6

Pos

1.9

3

3 (100)

8.1

Neg

0.0

0

0 (0)

8.5

Pos

0.07

3

3 (100)

9.1

Pos

0.2

2

0 (0)

9.2

Pos

2.5

3

0 (0)

9.3

Pos

1.7

3

0 (0)

9.5

Neg

0.0

3

0 (0)

9.8

Pos

0.3

3

0 (0)

9.9

Neg

0.0

0

0 (0)

Abbreviations: Neg, T. gondii qPCR-negative; Pos, T. gondii qPCR-positive

aChickens which were positive by ITS1 PCR

bOne mouse missing from table, it was inoculated with chicken tissues which were negative by ITS1 PCR and qPCR

Genotyping of 21 isolates from chickens indicated that 14 (67%) were atypical, 6 were ToxoDB genotype #1 (Type II) and one was genotype #2 (Type III) (Table 3 and Fig. 1). Of the 14 atypical genotypes, 7 were ToxoDB genotype #141, 3 were genotype #13, 3 were genotype #265 and 1 was genotype #264. No Type I genotypes were identified and no mixed infections were found. The genetic data were based on DNA from one mouse in each group of 3 mice inoculated with chicken tissues. For the two chickens which were positive by PCR but negative in the bioassay, no products could be amplified at any loci.
Table 3

Genetic characterisation of T. gondii isolated from chickens in St. Kitts

Chicken IDa

MAT titreb

Source of DNAc

No. of mice infectedd

Genetic characterisation

Isolate ID

SAG1

SAG2 (5’ and 3’)

Alt. SAG2

SAG3

BTUB

GRA6

c22-8

c29-2

L358

PK1

Apico

ToxoDB Genotype

1.6

1:6

Mouse

3 (0)

TgCkStK1

II or III

II

II

II

III

I

II

I

I

II

I

#264

  

Chicken

  

II or III

II

II

II

III

na

II

na

I

II

I

 

1.8

1:3

Mouse

3 (0)

TgCkStK2

II or III

II

II

III

II

II

II

III

III

II

III

#265

  

Chicken

  

na

na

II

III

na

II

na

na

III

II

III

 

2.1

1:800

Mouse

3 (3)

TgCkStK3

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

  

II or III

III

III

III

III

III

III

III

III

I

III

 

2.3

1:50

Mouse

3 (3)

TgCkStK4

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

  

II or III

III

III

III

III

III

III

III

III

I

III

 

3.2

0

Mouse

3 (0)

TgCkStK5

II or III

II

II

II

II

II

II

II

II

II

II

#1

  

Chicken

  

na

II

II

II

II

na

na

II

II

II

na

 

3.4

0

Mouse

3 (0)

TgCkStK6

II or III

II

II

II

II

II

II

II

II

II

II

#1

  

Chicken

  

II or III

II

II

II

II

II

II

II

II

II

II

 

3.5

1:6

Mouse

3 (3)

TgCkStK7

I

I

I

I

I

III

II

III

III

I

III

#13

  

Chicken

  

I

I

I

I

I

III

II

III

III

I

na

 

3.6

0

Mouse

3 (1)

TgCkStK8

II or III

II

II

II

II

II

II

II

II

II

II

#1

  

Chicken

  

II or III

II

na

II

II

na

II

II

II

II

II

 

3.8

1:10

Mouse

3 (2)

TgCkStK9

I

I

I

I

I

III

II

III

III

I

III

#13

  

Chicken

  

I

I

I

I

I

III

II

III

III

I

III

 

4.4

1:50

Mouse

3 (1)

TgCkStK10

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

  

na

na

na

na

na

na

na

na

na

na

na

 

5.1

1:3200

Mouse

3 (3)

TgCkStK11

I

I

I

I

I

III

II

III

III

I

III

#13

  

Chicken

  

I

I

I

I

I

III

II

III

III

I

III

 

5.2

1:25

Mouse

3 (2)

TgCkStK12

II or III

II

II

II

II

II

II

II

II

II

II

#1

  

Chicken

  

II or III

II

II

II

II

II

II

II

II

II

II

 

6.1

1:50

Mouse

3 (3)

TgCkStK13

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

  

II or III

III

III

III

III

III

III

III

III

I

III

 

6.2

1:6

Mouse

3 (3)

TgCkStK14

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

 

II or III

III

III

III

III

III

III

III

III

I

III

 

6.6

1:50

Mouse

3 (3)

TgCkStK15

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

  

II or III

III

na

III

III

III

III

III

III

I

III

 

8.5

1:25

Mouse

3 (3)

TgCkStK16

II or III

III

III

III

III

III

III

III

III

I

III

#141

  

Chicken

  

II or III

III

III

III

III

III

III

na

III

I

na

 

9.1

1:3

Mouse

2 (0)

TgCkStK17

II or III

II

II

III

II

II

II

III

III

II

III

#265

  

Chicken

  

II or III

II

II

III

II

II

II

III

III

II

III

 

9.2

1:10

Mouse

3 (0)

TgCkStK18

II or III

II

II

III

II

II

II

III

III

II

III

#265

  

Chicken

  

II or III

II

II

III

II

II

II

III

III

II

III

 

9.3

1:6

Mouse

3 (0)

TgCkStK19

II or III

II

III

III

III

III

III

III

III

III

III

#2

  

Chicken

  

II or III

II

III

III

III

III

III

na

III

III

na

 

9.5

1:3

Mouse

3 (0)

TgCkStK20

II or III

II

II

II

II

II

II

II

II

II

II

#1

  

Chicken

  

na

na

II

na

na

na

II

II

II

na

II

 

9.8

1:4000

Mouse

3 (0)

TgCkStK21

II or III

II

II

II

II

II

II

II

II

II

II

#1

  

Chicken

  

II or III

II

II

II

II

II

II

II

II

II

II

 

Abbreviations: MAT modified agglutination test, na not amplified

aLocation number followed by chicken number

b T. gondii MAT titre for chicken sera (1:6 or above was considered positive)

cDNA extracted from mouse brains or digested chicken tissues

dOut of 3 mice inoculated (number of mice euthanized early due to clinical toxoplasmosis)

Twenty one (21) chickens which tested T. gondii-positive by ITS1 PCR and also by bioassay (i.e. at least one out of three mice were positive for T. gondii) had their tissues tested by qPCR to quantify the amount of T. gondii DNA present. When comparing the percentage mortality of mice in the bioassay to the quantity of T. gondii DNA and the genotype present in the inocula, there was no significant effect of T. gondii DNA quantity (F (3,12) = 1.5, P = 0.265) but there was a significant effect of genotype (F (5,12) = 11.91, P < 0.0001). Post-hoc Fisher pairwise comparisons revealed that mice inoculated with genotypes #141 and #13 had significantly higher levels of mortality (P ≤ 0.05).

Discussion

The results of this study demonstrate a high prevalence of T. gondii in free-roaming chickens in St. Kitts and also reveal a greater genetic diversity of strains circulating on the island, with potentially different degrees of virulence to humans. Genotyping of 21 isolates in the present study revealed a predominance of atypical genotypes, the majority of which have previously been reported in St. Kitts. Genotypes #264 and #265 were only very recently isolated from feral dogs in St. Kitts and were avirulent for mice [22]. Genotypes #141 and #13 were previously isolated from feral cats in St. Kitts (TgCatStK1 and TgCatStK7, respectively) [18] and, therefore, further attests to the widespread environmental contamination with T. gondii oocysts. Genotype #141 has also been isolated from a fox in Pennsylvania, USA, and, notably, has been demonstrated to be acutely virulent to outbred mice even at low infection levels (10 tachyzoites) [27]. Genotype #13 has previously been isolated from chickens [16] and a goat [28] in Brazil, chickens [29] and a dog [30] in Grenada and a howler monkey in Brazil [31]. While these studies report that genotype #13 is avirulent for mice, in the present study 8 out of 9 mice inoculated with genotype #13 had to be euthanized due to clinical signs of toxoplasmosis. This may have been attributable to the quantity of T. gondii DNA present in the inocula rather than a reflection of virulence of the parasite but statistical analyses demonstrated that quantity of T. gondii DNA in the inocula was not a significant factor in mortality whereas genotype was, with significantly more euthanasias being recorded for mice inoculated with genotypes #13 and #141.

Strains which are virulent for mice are not necessarily virulent for humans but previous studies have reported isolating the Caribbean 1 isolate from an AIDS patient from Martinique where toxoplasmic encephalitis was recorded at autopsy [32], an AIDS patient from Guadeloupe who presented with toxoplasmic lymphadenopathy and had a previous history of toxoplasmic encephalitis [32], and a bone marrow transplant patient from Guadeloupe who died from pulmonary toxoplasmosis [32]. The Caribbean 1 isolate has been defined using microsatellite markers [33, 34] but in the case of toxoplasmic lymphadenopathy described above, the isolate has been genotyped using PCR-RFLP and defined as ToxoDB genotype #13 (Chunlei Su, personal communication). It is also possible that the other Caribbean 1 isolates (FDF-2007-HEN and CCH-2005-REN) are genotype #13 (Daniel Ajzenberg, personal communication). Further studies are currently underway in our laboratory to investigate the pathogenicity of the isolates from St. Kitts; however, the presence of potentially virulent strains circulating on the island is a public health issue and officials should take note.

Identifying 7 different genotypes from only 21 isolates would indicate that the overall genetic diversity of T. gondii on St. Kitts is relatively high. It appears that the Caribbean region is more in line with the diversity found in Central and South America than in North America and Europe. A recent study looking at geographical patterns of T. gondii genetic diversity revealed 156 different genotypes from 646 South/Central American isolates (24%) but only 9 genotypes from 64 European isolates (14%), 10 from 102 Asian isolates (10%), 13 from 141 African isolates (9%) and 40 from 501 North American isolates (8%) [35].

Worldwide serological prevalence of T. gondii in chickens varies widely (2–100%) and is dependent on the method of detection used and the source of chickens [10]. At present, there is no “gold standard” serological test for chickens although the MAT is considered the most specific [3638]. In the present study, MAT antibody titres of ≥ 1:6 were detected in 32% of chickens tested indicating that these animals have become infected with T. gondii in their environment in St. Kitts. The seroprevalence rate in St. Kitts is lower than that reported in the fellow Caribbean island of Grenada (52%) [12]; however, neither study documented the age of the animals which could influence results, since older animals are more likely to be seropositive for T. gondii [39, 40]. The domestic [17] and feral [18] cat populations in St. Kitts are known to have high T. gondii seroprevalence rates, suggesting that contamination with oocysts could be widespread on the island. Recent studies of dogs and livestock in St. Kitts and Nevis reported seroprevalences of 42% (dogs) [22], 26% (sheep) and 34% (goats) [21]. Together with the results of the current study, where chickens were collected from all over the island, it is evident that there is widespread contamination with T. gondii oocysts in St. Kitts. This could pose a potential public health issue given that sporulated, infective, T. gondii oocysts can survive in the environment for over a year [41, 42].

The results of the MAT (32% seropositive) were not too dissimilar to the results of the bioassay (26% Toxoplasma-positive) and ITS1 PCR on the digested tissues (28% Toxoplasma-positive) suggesting that the MAT is a good serological indicator of T. gondii infection. However, of seven chickens which were deemed seronegative by MAT (titre ≤ 1:3), six were positive by bioassay (mice were positive by ITS1 PCR and/or serology) and all seven were ITS1 PCR positive (DNA extracted from homogenised chicken tissues). Previous reports have demonstrated that T. gondii could be isolated from defined seronegative chickens [12, 39] indicating that MAT is perhaps not as sensitive at detecting early stages of infection when antibody levels are lower, or it could indicate that the chickens were persistently infected and the antibody levels had declined [43]. A previous study investigating the persistence of T. gondii in tissues of experimentally infected poultry reported decreasing antibody titres in chickens four weeks post-infection [43]. This would suggest that seroprevalence studies may underestimate the true prevalence of T. gondii in free-roaming chickens.

It is of note that nine chickens tested positive by MAT but were negative in the bioassay and ITS1 PCR. This discrepancy may have been due to the inhomogeneous distribution of T. gondii tissue cysts in the digested tissues or because the tissues were no longer harbouring cysts. Chickens are clinically resistant to T. gondii [10] and in a recent study of experimentally infected chickens, only 4 out of 192 tested positive by PCR and only one tissue (heart) was still found to be positive by ten weeks post-infection [43].

Although we did not test breast muscle or thigh muscle, it is possible that these tissues may have contained viable T. gondii tissue cysts [10, 44], highlighting a possible public health risk to the inhabitants of St. Kitts who handle or consume locally produced chicken meat [10]. Also, given the evidence for environmental contamination with oocysts, there is also a potential for transmission to the population through contaminated water [45]. Until very recently, there was no data on T. gondii infection rates in people in St. Kitts. Dubey et al. [22] conducted a study on pregnant women in the Caribbean and reported that 8 out of 44 (18%) women in St. Kitts were seropositive for T. gondii by MAT. This was comparable to Bermuda (18%) but lower than other Caribbean islands, including Dominica (59%), St. Vincent and the Grenadines (54%), St. Lucia (53%), Grenada (37%), Montserrat (33%), and Antigua and Barbuda (32%) [22]. Chicken is a popular meat in the Caribbean and is frequently eaten barbequed which could pose an infection risk if the meat is infected and not cooked thoroughly. However, the tendency in this region is to consume meat (not just chicken) well-done so the risk of infection is likely to be low, since tissue cysts are killed at temperatures of over 67 °C for 10 min [46]. People may be at more risk of infection from a lack of hand washing after handling raw infected meat, particularly in the case of backyard farming where chickens are killed at home and their viscera may be improperly handled and disposed of [10].

Conclusion

In summary, there is a greater genetic diversity of T. gondii circulating in the Caribbean region, with potentially different degrees of virulence to humans. The study also confirms that the environment in St. Kitts is contaminated with T. gondii oocysts and highlights chicken meat as a potentially important source of T. gondii infection if it is handled with poor hygiene standards or if it is consumed undercooked.

Declarations

Acknowledgements

The authors would like to thank Prof. Elaine Watson for supporting the collaboration between MRI and RUSVM. The authors would also like to thank Dr. Pompei Bolfa and Dr. Sean Callanan for performing the chicken post mortems, Kevin Bowry for facilitating the collection of chickens, Dr. Xiemena Valderrama for assistance with in vitro cultures, and Shaun Yount and Dominique Aubert for technical assistance.

Funding

Funding for this study was provided by Ross University School of Veterinary Medicine, the Moredun Research Institute and the Scottish Government (Rural and Environment Science and Analytical Services Division).

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Authors’ contributions

CMH processed chicken tissues, performed mouse post mortems, DNA extractions, PCRs and all genotyping. CMH also contributed to the study design and prepared the manuscript. PJK contributed to the study design, sought ethical approval for the study, organised collection of the chickens and revised the manuscript. KB and TMC assisted with chicken post mortems, mouse inoculations and mouse post mortems. KB also assisted with DNA extractions. HH and DM both assisted with chicken and mouse post mortems. IV performed the chicken serology and read the manuscript. CS performed genotyping for the alt.SAG2 marker and confirmed other genotyping results. LI and FK contributed to the study design, offered technical expertise in the genotyping and also revised the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study was performed in accordance with current IACUC legislation on ethical and welfare recommendations. Ethical approval was obtained from IACUC at RUSVM (Project Submission 30/020).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Moredun Research Institute
(2)
Ross University School of Veterinary Medicine
(3)
School of Applied Science, Temasek Polytechnic
(4)
EA 3800, UFR Medecine, SFR CAP-SANTE, University of Reims Champagne Ardenne
(5)
Laboratory of Parasitology, National Reference Centre on Toxoplasmosis, Hospital Maison Blanche, CHU Reims
(6)
Department of Microbiology, University of Tennessee

References

  1. Dubey JP. The history of Toxoplasma gondii - the first 100 years. J Eukaryot Microbiol. 2008;55:467–75.View ArticlePubMedGoogle Scholar
  2. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385–94.View ArticlePubMedGoogle Scholar
  3. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217–58.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Scientific opinion of the Panel on Biological Hazards on a request from EFSA on surveillance and monitoring of Toxoplasma in humans, food and animals. The EFSA Journal 2007;583:1-64.Google Scholar
  5. Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995;172:1561–6.View ArticlePubMedGoogle Scholar
  6. Ajzenberg D, Banuls AL, Tibayrenc M, Darde ML. Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int J Parasitol. 2002;32:27–38.View ArticlePubMedGoogle Scholar
  7. Ferreira IM, Vidal JE, de Mattos CC, de Mattos LC, Qu D, Su C, Pereira-Chioccola VL. Toxoplasma gondii isolates: multilocus RFLP-PCR genotyping from human patients in Sao Paulo State, Brazil identified distinct genotypes. Exp Parasitol. 2011;129:190–5.View ArticlePubMedGoogle Scholar
  8. Carme B, Demar M, Ajzenberg D, Darde ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis. 2009;15:656–8.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Dubey JP, Graham DH, Blackston CR, Lehmann T, Gennari SM, Ragozo AM, et al. Biological and genetic characterisation of Toxoplasma gondii isolates from chickens (Gallus domesticus) from Sao Paulo, Brazil: unexpected findings. Int J Parasitol. 2002;32:99–105.View ArticlePubMedGoogle Scholar
  10. Dubey JP. Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis and public health significance. Zoonoses Public Health. 2010;57:60–73.View ArticlePubMedGoogle Scholar
  11. Dubey JP, Lopez B, Alvarez M, Mendoza C, Lehmann T. Isolation, tissue distribution, and molecular characterization of Toxoplasma gondii from free-range chickens from Guatemala. J Parasitol. 2005;91:955–7.View ArticlePubMedGoogle Scholar
  12. Dubey JR, Bhaiyat MI, de Allie C, Macpherson CN, Sharma RN, Sreekumar C, et al. Isolation, tissue distribution, and molecular characterization of Toxoplasma gondii from chickens in Grenada, West Indies. J Parasitol. 2005;91:557–60.View ArticlePubMedGoogle Scholar
  13. Sreekumar C, Graham DH, Dahl E, Lehmann T, Raman M, Bhalerao DP, et al. Genotyping of Toxoplasma gondii isolates from chickens from India. Vet Parasitol. 2003;118:187–94.View ArticlePubMedGoogle Scholar
  14. Dubey JP, Karhemere S, Dahl E, Sreekumar C, Diabate A, Dabire KR, et al. First biologic and genetic characterization of Toxoplasma gondii isolates from chickens from Africa (Democratic Republic of Congo, Mali, Burkina Faso, and Kenya). J Parasitol. 2005;91:69–72.View ArticlePubMedGoogle Scholar
  15. Dubey JP, Vianna MC, Sousa S, Canada N, Meireles S, Correia da Costa JM, et al. Characterization of Toxoplasma gondii isolates in free-range chickens from Portugal. J Parasitol. 2006;92:184–6.View ArticlePubMedGoogle Scholar
  16. Dubey JP, Velmurugan GV, Chockalingam A, Pena HF, de Oliveira LN, Leifer CA, et al. Genetic diversity of Toxoplasma gondii isolates from chickens from Brazil. Vet Parasitol. 2008;157:299–305.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Moura L, Kelly P, Krecek RC, Dubey JP. Seroprevalence of Toxoplasma gondii in cats from St. Kitts, West Indies. J Parasitol. 2007;93:952–3.View ArticlePubMedGoogle Scholar
  18. Dubey JP, Moura L, Majumdar D, Sundar N, Velmurugan GV, Kwok OC, Kelly P, et al. Isolation and characterization of viable Toxoplasma gondii isolates revealed possible high frequency of mixed infection in feral cats (Felis domesticus) from St. Kitts, West Indies. Parasitology. 2009;136:589–94.View ArticlePubMedGoogle Scholar
  19. Hamilton CM, Katzer F, Beierschmitt A, Soto E, Innes EA, Kelly PJ. First report of Toxoplasma gondii seroprevalence in wild-caught Caribbean African green monkeys. Parasit Vectors. 2014;7:571–4.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Hamilton CM, Katzer F, Innes EA, Kelly PJ. Seroprevalence of Toxoplasma gondii in small ruminants from four Caribbean islands. Parasit Vectors. 2014;7:449–552.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Hamilton CM, Kelly PJ, Bartley PM, Burrells A, Porco A, Metzler D, et al. Toxoplasma gondii in livestock in St. Kitts and Nevis Parasit Vectors. 2015;8:166–74.View ArticlePubMedGoogle Scholar
  22. Dubey JP, Verma SK, Villena I, Aubert D, Geers R, Su C, et al. Toxoplasmosis in the Caribbean islands: literature review, seroprevalence in pregnant women in ten countries, isolation of viable Toxoplasma gondii from dogs from St. Kitts, West Indies with report of new T. gondii genetic types. Parasitol Res. 2016;115:1627–34.View ArticlePubMedGoogle Scholar
  23. Dubey JP, Desmonts G. Serological responses of equids fed Toxoplasma gondii oocysts. Equine Vet J. 1987;19:337–9.View ArticlePubMedGoogle Scholar
  24. Katzer F, Canton G, Burrells A, Palarea-Albaladejo J, Horton B, Bartley PM, et al. Immunization of lambs with the S48 strain of Toxoplasma gondii reduces tissue cyst burden following oral challenge with a complete strain of the parasite. Vet Parasitol. 2014;205:46–56.View ArticlePubMedGoogle Scholar
  25. Burrells A, Bartley PM, Zimmer IA, Roy S, Kitchener AC, Meredith A, et al. Evidence of the three main clonal Toxoplasma gondii lineages from wild mammalian carnivores in the UK. Parasitology. 2013;140:1768–76.View ArticlePubMedGoogle Scholar
  26. Burrells A, Opsteegh M, Pollock KG, Alexander CL, Chatterton J, Evans R, et al. The prevalence and genotypic analysis of Toxoplasma gondii from individuals in Scotland, 2006-2012. Parasit Vectors. 2016;9:324.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Dubey JP, Van Why K, Verma SK, Choudhary S, Kwok OC, Khan A, et al. Genotyping Toxoplasma gondii from wildlife in Pennsylvania and identification of natural recombinants virulent to mice. Vet Parasitol. 2014;200:74–84.View ArticlePubMedGoogle Scholar
  28. Ragozo AM, Yai LE, Oliveira LN, Dias RA, Goncalves HC, Azevedo SS, et al. Isolation of Toxoplasma gondii from goats from Brazil. J Parasitol. 2009;95:323–6.View ArticlePubMedGoogle Scholar
  29. Rajendran C, Su C, Dubey JP. Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between populations. Infect Genet Evol. 2012;12:359–68.View ArticlePubMedGoogle Scholar
  30. Dubey JP, Tiwari K, Chikweto A, Deallie C, Sharma R, Thomas D, et al. Isolation and RFLP genotyping of Toxoplasma gondii from the domestic dogs (Canis familiaris) from Grenada, West Indies revealed high genetic variability. Vet Parasitol. 2013;197:623–6.View ArticlePubMedGoogle Scholar
  31. Pena HF, Marvulo MF, Horta MC, Silva MA, Silva JC, Siqueira DB, et al. Isolation and genetic characterisation of Toxoplasma gondii from a red-handed howler monkey (Alouatta belzebul), a jaguarundi (Puma yagouaroundi), and a black-eared opossum (Didelphis aurita) from Brazil. Vet Parasitol. 2011;175:377–81.View ArticlePubMedGoogle Scholar
  32. Ajzenberg D, Yera H, Marty P, Paris L, Dalle F, Menotti J, et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis. 2009;199:1155–67.View ArticlePubMedGoogle Scholar
  33. Ajzenberg D, Lamaury I, Demar M, Vautrin C, Cabie A, Simon S, et al. Performance testing of PCR assay in blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients from the French Departments of America and genetic diversity of Toxoplasma gondii: A prospective and multicentric study. PLoS Negl Trop Dis. 2016;10, e0004790.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Ajzenberg D, Banuls AL, Su C, Dumetre A, Demar M, Carme B, Darde ML. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol. 2004;34:1185–96.View ArticlePubMedGoogle Scholar
  35. Shwab EK, Zhu XQ, Majumdar D, Pena HF, Gennari SM, Dubey JP, Su C. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;141:453–61.View ArticlePubMedGoogle Scholar
  36. Dubey JP, Laurin E, Kwowk OC. Validation of the modified agglutination test for the detection of Toxoplasma gondii in free-range chickens by using cat and mouse bioassay. Parasitology. 2016;143:314–9.View ArticlePubMedGoogle Scholar
  37. Dubey JP, Graham DH, Dahl E, Sreekumar C, Lehmann T, Davis MF, Morishita TY. Toxoplasma gondii isolates from free-ranging chickens from the United States. J Parasitol. 2003;89:1060–2.View ArticlePubMedGoogle Scholar
  38. Casartelli-Alves L, Boechat VC, Macedo-Couto R, Ferreira LC, Nicolau JL, Neves LB, et al. Sensitivity and specificity of serological tests, histopathology and immunohistochemistry for detection of Toxoplasma gondii infection in domestic chickens. Vet Parasitol. 2014;204:346–51.View ArticlePubMedGoogle Scholar
  39. Zhao G, Shen B, Xie Q, Xu LX, Yan RF, Song XK, Hassan IA, Li XR. Detection of Toxoplasma gondii in free-range chickens in China based on circulating antigens and antibodies. Vet Parasitol. 2012;185:72–7.View ArticlePubMedGoogle Scholar
  40. Katzer F, Brulisauer F, Collantes-Fernandez E, Bartley PM, Burrells A, Gunn G, et al. Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection. Vet Res. 2011;42:121.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Frenkel JK, Ruiz A, Chinchilla M. Soil survival of toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg. 1975;24:439–43.PubMedGoogle Scholar
  42. Dubey JP. Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol. 1998;84:862–5.View ArticlePubMedGoogle Scholar
  43. Geuthner AC, Koethe M, Ludewig M, Pott S, Schares G, Daugschies A, Bangoura B. Persistence of Toxoplasma gondii tissue stages in poultry over a conventional fattening cycle. Parasitology. 2014;141:1359–64.View ArticlePubMedGoogle Scholar
  44. Hill DE, Dubey JP: Toxoplasmosis. US Geological Survey Circular 1389 2014. http://dx.doi.org/10.3133/cir1389.
  45. Wells B, Shaw H, Innocent G, Guido S, Hotchkiss E, Parigi M, et al. Molecular detection of Toxoplasma gondii in water samples from Scotland and a comparison between the 529bp real-time PCR and ITS1 nested PCR. Water Res. 2015;87:175–81.View ArticlePubMedGoogle Scholar
  46. Dubey JP, Kotula AW, Sharar A, Andrews CD, Lindsay DS. Effect of high temperature on infectivity of Toxoplasma gondii tissue cysts in pork. J Parasitol. 1990;76:201–4.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement